⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2683423 | 0.86 | — | — | |
| SCHEMBL4069647 | 0.79 | — | — | |
| SCHEMBL9052390 | 0.75 | — | — | |
| SCHEMBL4612501 | 0.75 | — | — | |
| SCHEMBL9261125 | 0.71 | — | — | |
| SCHEMBL11565964 | 0.70 | — | — | |
| SCHEMBL9257474 | 0.70 | EPHX1 (0.33) | — | |
| SCHEMBL4059442 | 0.70 | — | — | |
| SCHEMBL9255078 | 0.70 | — | — | |
| SCHEMBL8996656 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040266864-A1 | Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram | SEPRACOR INC. | 2004-12-30 | — | — | US | claimed |
| EP-1446396-A1 | METHODS FOR TREATING DEPRESSION AND OTHER CNS DISORDERS USING ENANTIOMERICALLY ENRICHED DESMETHYL- AND DIDESMETHYL-METABOLITES OF CITALOPRAM | Sepracor, Inc. (US) | 2004-08-18 | — | — | EP | claimed |
| WO-2003040121-A1 | METHODS FOR TREATING DEPRESSION AND OTHER CNS DISORDERS USING ENANTIOMERICALLY ENRICHED DESMETHYL- AND DIDESMETHYL-METABOLITES OF CITALOPRAM | SEPRACOR, INC. (US) | 2003-05-15 | — | — | WO | claimed |
| US-6281232-B1 | AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES | NOVO NORDISK A/S (DK) | 2001-08-28 | — | — | US | disclosed |
| US-6265419-B1 | IRRITABLE BOWEL DISORDER | NOVO NORDISK A/S (DK) | 2001-07-24 | — | — | US | disclosed |
| CN-1046722-C | Heterocyclic compounds and their preparation and use | NOVO NORDISK AS (DK) | 1999-11-24 | — | — | CN | disclosed |
| US-5710151-A | ADMINISTERING A THIADIAZOLE OR AN OXADIAZOLE DERIVATIVE TO A SUBJECT | MUHLHAUSER MARK A (US) | 1998-01-20 | — | — | US | disclosed |
| US-5679686-A | TREATING SCHIZOPHRENIA BY ADMINISTERING THIADIAZOLE OR OXADIAZOLE DERIVATIVES | NOVO NORDISK A/S (DK) | 1997-10-21 | — | — | US | disclosed |
| US-5677313-A | ADMINISTERING 1,2,5-THIADIAZOLYL-AZABICYCLONONENE DERIVATIVES | NOVO NORDISK A/S (DK) | 1997-10-14 | — | — | US | disclosed |
| US-5663182-A | ADMINISTERING AN AZABICYCLIC RING SUBSTITUTED THIADIAZOLE OR OXADIAZOLE TO A MAMMAL | BYMASTER FRANKLIN PORTER (US) | 1997-09-02 | — | — | US | disclosed |
| US-5641791-A | USEFUL AS STIMULANTS OF COGNITIVE FUNCTION OF FOREBRAIN AND HIPPOCAMPUS OF MAMMALS AND IN THE TREATMENT OF ALZHIEMER'S DISEASE, SEVERE PAIN AND GLAUCOMA | NOVO NORDISK A.S (DK) | 1997-06-24 | — | — | US | disclosed |
| US-5635449-A | Arylthioalkyl- and arylthioalkenylphosphonic acids and derivatives thereof useful as herbicidal agents | AMERICAN CYANAMID COMPANY (US) | 1997-06-03 | — | — | US | disclosed |
| US-5574043-A | ALZHEIMERS, GLAUCOMA, ANALGESIC | NOVO NORDISK A/S (DK) | 1996-11-12 | — | — | US | disclosed |
| US-5527813-A | THERAPEUTICALLY ACTIVE AZABICYCLIC COMPOUNDS USEFUL AS STIMULANTS OF THE COGNITIVE FUNCTION OF THE FOREBRAIN AND IN THE TREATMENT OF ALZHEIMER'S DISEASE | NOVO NORDISK A/S (DK) | 1996-06-18 | — | — | US | disclosed |
| CN-1121349-A | Heterocyclic compounds and their preparation and use | NOVO NORDISK AS (DK) | 1996-04-24 | — | — | CN | disclosed |